Analysts' Actions: ANF BMY CERN FSLR MGM
NEW YORK (TheStreet) -- CHANGE IN RATINGS
Abercrombie & Fitch (ANF) downgraded at Baird from Outperform to Neutral, Robert Baird said. $32 price target. Company is seeing lower sales, especially in Europe.
Abercrombie & Fitch downgraded at Piper from Overweight to Neutral, Piper Jaffray said. $28 price target. Company could continue to struggle for several quarters.
Bristol-Myers (BMY) downgraded at Leerink from Outperform to Market Perform, Leerink Swann said. Stock could be rangebound, following the failure of its Hepatitis-C treatment.
Cerner (CERN) downgraded at Leerink to Market Perform, Leerink Swann said. Bookings growth is starting to decelerate.
Embraer(ERJ) rated new Buy at UBS. $32 price target. Bizjets / defense / aftermarket to drive growth.
First Solar (FSLR) upgraded at Baird from Neutral to Outperform, Robert Baird said. $30 price target. Company has a solid balance sheet and pipeline execution remains strong.
First Solar upgraded at Cantor from Hold to Buy, Cantor Fitzgerald said. Company can replace its project pipeline and transition to a more sustainable business model.
First Solar upgraded at ThinkEquity from Sell to Hold, ThinkEquity said. $16 price target. Company boosted its guidance and appears to have prior issues under control.
HSN(HSNI) downgraded at Stifel from Buy to Hold, Stifel Nicolaus said. Valuation call.
MGM Resorts (MGM) downgraded at BofA/Merrill to Neutral, Bank of America/Merrill Lynch said. $11 price target. Second half recovery may not materialize in Las Vegas.
Pharmacyclics(PCYC) downgraded at Needham from Buy to Hold, Needham said. Valuation call.
Ralcorp (RAH) upgraded at Credit Suisse from Neutral to Outperform, Credit Suisse said. $75 price target. Company is cutting costs.
Stryker (SYK) downgraded at Piper from Overweight to Neutral, Piper Jaffray said. $61 price target. Expect a challenging environment for hospital capital spending.
Titanium Metals (TIE) upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. Valuation call, based on a $17 price target.